Fundraising FoxLykos Therapeutics fka MAPS PBC
7 known investors
Find your way into Lykos Therapeutics fka MAPS PBC
Sign up to see every warm intro you have to Lykos Therapeutics fka MAPS PBC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lykos Therapeutics fka MAPS PBC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder. The company applies decades of evidence-based research to create new therapeutic approaches for patients with unmet mental healthcare needs.
Investors · 7
Frequently asked questions
- What does Lykos Therapeutics fka MAPS PBC do?
- Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder. The company applies decades of evidence-based research to create new therapeutic approaches for patients with unmet mental healthcare needs.
- Who are Lykos Therapeutics fka MAPS PBC's investors?
- Lykos Therapeutics fka MAPS PBC's investors include JourneyOne Ventures, Lauder Partners, Leafy Tunnel, Solari Capital, Tabula Rasa Ventures, WGD Capital, L.P., XEIA Venture Partners.